PHOTRONICS INC (PLAB) Stock Fundamental Analysis

NASDAQ:PLAB • US7194051022

37.43 USD
-1.23 (-3.18%)
At close: Feb 27, 2026
37.6 USD
+0.17 (+0.45%)
After Hours: 2/27/2026, 8:27:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

PLAB gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 115 industry peers in the Semiconductors & Semiconductor Equipment industry. PLAB scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PLAB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • PLAB had positive earnings in the past year.
  • PLAB had a positive operating cash flow in the past year.
  • In the past 5 years PLAB has always been profitable.
  • In the past 5 years PLAB always reported a positive cash flow from operatings.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • With a decent Return On Assets value of 7.56%, PLAB is doing good in the industry, outperforming 73.91% of the companies in the same industry.
  • The Return On Equity of PLAB (11.62%) is better than 76.52% of its industry peers.
  • PLAB has a Return On Invested Capital of 10.17%. This is amongst the best in the industry. PLAB outperforms 82.61% of its industry peers.
  • PLAB had an Average Return On Invested Capital over the past 3 years of 12.29%. This is in line with the industry average of 10.63%.
Industry RankSector Rank
ROA 7.56%
ROE 11.62%
ROIC 10.17%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of PLAB (16.06%) is better than 75.65% of its industry peers.
  • PLAB's Profit Margin has improved in the last couple of years.
  • PLAB has a better Operating Margin (24.51%) than 82.61% of its industry peers.
  • In the last couple of years the Operating Margin of PLAB has grown nicely.
  • With a Gross Margin value of 35.30%, PLAB is not doing good in the industry: 60.87% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of PLAB has grown nicely.
Industry RankSector Rank
OM 24.51%
PM (TTM) 16.06%
GM 35.3%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PLAB is creating some value.
  • The number of shares outstanding for PLAB has been reduced compared to 1 year ago.
  • PLAB has less shares outstanding than it did 5 years ago.
  • PLAB has a better debt/assets ratio than last year.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • PLAB has an Altman-Z score of 4.03. This indicates that PLAB is financially healthy and has little risk of bankruptcy at the moment.
  • With a Altman-Z score value of 4.03, PLAB perfoms like the industry average, outperforming 53.91% of the companies in the same industry.
  • The Debt to FCF ratio of PLAB is 0.00, which is an excellent value as it means it would take PLAB, only 0.00 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of PLAB (0.00) is better than 86.09% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that PLAB is not too dependend on debt financing.
  • PLAB's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. PLAB outperforms 73.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.03
ROIC/WACC0.96
WACC10.58%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • PLAB has a Current Ratio of 5.37. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
  • PLAB has a Current ratio of 5.37. This is in the better half of the industry: PLAB outperforms 73.91% of its industry peers.
  • A Quick Ratio of 4.99 indicates that PLAB has no problem at all paying its short term obligations.
  • PLAB's Quick ratio of 4.99 is fine compared to the rest of the industry. PLAB outperforms 75.65% of its industry peers.
Industry RankSector Rank
Current Ratio 5.37
Quick Ratio 4.99
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • PLAB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.92%.
  • PLAB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.81% yearly.
  • The Revenue has decreased by -2.04% in the past year.
  • The Revenue has been growing slightly by 6.85% on average over the past years.
EPS 1Y (TTM)1.92%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%17.31%
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%6.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.62% on average over the next years.
  • PLAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.23% yearly.
EPS Next Y7.02%
EPS Next 2Y5.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.7%
Revenue Next 2Y6.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.66, which indicates a rather expensive current valuation of PLAB.
  • 92.17% of the companies in the same industry are more expensive than PLAB, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, PLAB is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 16.53, PLAB is valued correctly.
  • Based on the Price/Forward Earnings ratio, PLAB is valued cheaper than 90.43% of the companies in the same industry.
  • PLAB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.05.
Industry RankSector Rank
PE 17.66
Fwd PE 16.53
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PLAB is valued cheaper than 100.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, PLAB is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 37.11
EV/EBITDA 5.34
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PLAB does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of PLAB may justify a higher PE ratio.
PEG (NY)2.51
PEG (5Y)0.57
EPS Next 2Y5.62%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PLAB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHOTRONICS INC

NASDAQ:PLAB (2/27/2026, 8:27:02 PM)

After market: 37.6 +0.17 (+0.45%)

37.43

-1.23 (-3.18%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-25
Earnings (Next)05-26
Inst Owners94.12%
Inst Owner Change2.09%
Ins Owners3.91%
Ins Owner Change0.82%
Market Cap2.21B
Revenue(TTM)849.29M
Net Income(TTM)136.40M
Analysts85
Price Target43.2 (15.42%)
Short Float %5.45%
Short Ratio1.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.53%
Min EPS beat(2)29.38%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)12.6%
Min EPS beat(4)-19.14%
Max EPS beat(4)31.69%
EPS beat(8)4
Avg EPS beat(8)2.09%
EPS beat(12)6
Avg EPS beat(12)2.67%
EPS beat(16)9
Avg EPS beat(16)6.93%
Revenue beat(2)2
Avg Revenue beat(2)1.95%
Min Revenue beat(2)0.82%
Max Revenue beat(2)3.08%
Revenue beat(4)2
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)3.08%
Revenue beat(8)3
Avg Revenue beat(8)-2.37%
Revenue beat(12)5
Avg Revenue beat(12)-1.19%
Revenue beat(16)8
Avg Revenue beat(16)-0.48%
PT rev (1m)0%
PT rev (3m)28.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.72%
EPS NY rev (1m)0%
EPS NY rev (3m)6.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.76%
Valuation
Industry RankSector Rank
PE 17.66
Fwd PE 16.53
P/S 2.6
P/FCF 37.11
P/OCF 8.92
P/B 1.88
P/tB 1.88
EV/EBITDA 5.34
EPS(TTM)2.12
EY5.66%
EPS(NY)2.26
Fwd EY6.05%
FCF(TTM)1.01
FCFY2.69%
OCF(TTM)4.2
OCFY11.21%
SpS14.38
BVpS19.87
TBVpS19.87
PEG (NY)2.51
PEG (5Y)0.57
Graham Number30.79
Profitability
Industry RankSector Rank
ROA 7.56%
ROE 11.62%
ROCE 12.7%
ROIC 10.17%
ROICexc 15.86%
ROICexgc 15.86%
OM 24.51%
PM (TTM) 16.06%
GM 35.3%
FCFM 7.01%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
ROICexc(3y)20.09%
ROICexc(5y)18.3%
ROICexgc(3y)20.09%
ROICexgc(5y)18.3%
ROCE(3y)15.36%
ROCE(5y)14.68%
ROICexgc growth 3Y-10.62%
ROICexgc growth 5Y18.95%
ROICexc growth 3Y-10.62%
ROICexc growth 5Y19.05%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 242.55%
Cap/Sales 22.16%
Interest Coverage 250
Cash Conversion 86.71%
Profit Quality 43.67%
Current Ratio 5.37
Quick Ratio 4.99
Altman-Z 4.03
F-Score6
WACC10.58%
ROIC/WACC0.96
Cap/Depr(3y)187.79%
Cap/Depr(5y)164.84%
Cap/Sales(3y)17.34%
Cap/Sales(5y)16.42%
Profit Quality(3y)93.18%
Profit Quality(5y)98.28%
High Growth Momentum
Growth
EPS 1Y (TTM)1.92%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%17.31%
EPS Next Y7.02%
EPS Next 2Y5.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%6.1%
Revenue Next Year5.7%
Revenue Next 2Y6.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.03%
EBIT growth 3Y-0.59%
EBIT growth 5Y26.64%
EBIT Next Year48.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-54.32%
FCF growth 3Y-28.46%
FCF growth 5Y-3.72%
OCF growth 1Y-5.22%
OCF growth 3Y-3.44%
OCF growth 5Y11.62%

PHOTRONICS INC / PLAB FAQ

What is the fundamental rating for PLAB stock?

ChartMill assigns a fundamental rating of 6 / 10 to PLAB.


Can you provide the valuation status for PHOTRONICS INC?

ChartMill assigns a valuation rating of 5 / 10 to PHOTRONICS INC (PLAB). This can be considered as Fairly Valued.


How profitable is PHOTRONICS INC (PLAB) stock?

PHOTRONICS INC (PLAB) has a profitability rating of 7 / 10.


What is the valuation of PHOTRONICS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PHOTRONICS INC (PLAB) is 17.66 and the Price/Book (PB) ratio is 1.88.